
由前沿细胞设计技术塑造的医疗未来
细胞设计医学研究所(RICeD)旨在成为国际化的研发中心,通过创新的细胞设计技术——山口大学的核心优势,不断培育出下一代细胞和基因疗法的创新成果。
RICeD还致力于推动基于创新技术的前沿免疫疗法和基因组医学的实际应用,开发用于癌症和遗传病等疑难疾病的治疗方法,并在伴侣动物中应用和验证这些创新疗法。
通过在人类和伴侣动物之间建立知识互通的积极循环,RICeD将努力通过技术的社会应用形成药物发现生态系统,推动地方社区发展,通过产业创造培养人才,并延长人类和伴侣动物的健康寿命。
- ALL
- News
- Thesis
- Recruiting

News
2025.02.26
*Announcement* Presentation at the Lunch Meeting of the Research Institute and Center Conference

News
2025.02.13
*Notice* Currently exhibiting at the Osaka-Kansai Expo pre-event!

News
2025.02.07
*Notice* UBE Corporation and UBE Corporation Commence Joint Research on Novel Combination Cancer Immunotherapy

News
2025.01.21
*Notice* We are challenging crowdfunding!

News
2024.12.18
*Report* “The Frontiers of Regenerative and Cellular Medicine: Changing the Future of Medicine” was held as an open-house event.

News
2024.12.16
*Report* Seminar on Medical Information Systems Research was held.

News
2024.12.13
*Report* FOCS Project Selected

News
2024.11.11
*Information* Seminar of the Division of Medical Informatics and Systems Research will be held on December 13.

Thesis
2025.03.03
Sodium ferrous citrate in 5-Aminolevulinic acid supplements suppresses the effector function of feline lymphocytes by reducing the mitochondrial membrane potential

Thesis
2025.02.05
Cholesterol ensures ciliary polycystin-2 localization to prevent polycystic kidney disease

Thesis
2025.01.27
Pharmacokinetics of Hydrogen During Hydrogen-Saturated Saline Infusion in Pigs

Thesis
2025.01.16
Concomitant Administration of Dantrolene is Sufficient to Protect Against Doxorubicin-Induced Cardiomyopathy

Thesis
2024.12.13
Establishment of a novel amyotrophic lateral sclerosis patient (TARDBP N345K/+)-derived brain microvascular endothelial cell model reveals defective Wnt/β-catenin signaling: investigating diffusion barrier dysfunction and immune cell interaction.

Thesis
2024.10.30
Kinetics of pro- and anti-inflammatory spike-specific cellular immune responses in long-term care facility residents after COVID-19 mRNA primary and booster vaccination: a prospective longitudinal study in Japan.

Thesis
2024.10.08
Calcineurin-mediated dephosphorylation stabilizes E2F1 protein by suppressing binding of the FBXW7 ubiquitin ligase subunit

Thesis
2024.09.28
Establishment of Noninvasive Prediction Models for the Diagnosis of Uterine Leiomyoma Subtypes
The article could not be found.

Thesis
2025.03.03
Sodium ferrous citrate in 5-Aminolevulinic acid supplements suppresses the effector function of feline lymphocytes by reducing the mitochondrial membrane potential

News
2025.02.26
*Announcement* Presentation at the Lunch Meeting of the Research Institute and Center Conference

News
2025.02.13
*Notice* Currently exhibiting at the Osaka-Kansai Expo pre-event!

News
2025.02.07
*Notice* UBE Corporation and UBE Corporation Commence Joint Research on Novel Combination Cancer Immunotherapy

Thesis
2025.02.05
Cholesterol ensures ciliary polycystin-2 localization to prevent polycystic kidney disease

Thesis
2025.01.27
Pharmacokinetics of Hydrogen During Hydrogen-Saturated Saline Infusion in Pigs

News
2025.01.21
*Notice* We are challenging crowdfunding!

Thesis
2025.01.16
Concomitant Administration of Dantrolene is Sufficient to Protect Against Doxorubicin-Induced Cardiomyopathy
RICeD捐款请求
我们正在推进尖端癌症免疫疗法的开发,以治愈更多患者。
我们还致力于将全球首创的基因编辑技术应用于伴侣动物的遗传病治疗,并将研究成果进一步应用于人类医学,以延长人类和伴侣动物的健康寿命。为实现这些目标,并持续推动研究成果的社会应用,我们真诚地请求您的支持。
ー Follow us! ー